Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Olivia Tong
RJ
Olivia Tong
Raymond James
Wall Street Analyst
★☆☆☆☆
#2469
on 13Foresight · ranked by our own returns
33%
Success Rate
-18.8%
Average Return
7 of 21 calls profitable · -33.6% vs benchmark
📈 Across the calls we could measure, roughly 33% of Olivia Tong's ratings turned a profit when each position was held for 1 year — averaging -18.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

20 Buy 6 Hold 0 Sell
Olivia's Stock Coverage 22 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
ELF
e.l.f. Beauty
 May 21, 2026 BUY Strong Buy
+24.1% avg upside
18 analysts
$85.00
36.50% Upside
 ·
EL
The Estée Lauder Companies
 Mar 19, 2026 BUY Buy
+20.6% avg upside
33 analysts
$130.00
57.60% Upside
 -3.3%
ULTA
Ulta Beauty
 Jan 21, 2026 BUY Strong Buy
+29.6% avg upside
32 analysts
$790.00
75.31% Upside
 -34.1%
SBH
Sally Beauty
 Jan 21, 2026 BUY Buy
+41.0% avg upside
12 analysts
$19.00
45.60% Upside
 -22.2%
CHD
Church & Dwight
 Jan 21, 2026 BUY Buy
+4.9% avg upside
24 analysts
$100.00
2.70% Upside
 +6.8%
BBWI
Bath & Body Works
 Nov 12, 2025 HOLD Hold
+55.7% avg upside
28 analysts
 — -22.1%
PG
Procter & Gamble
 Oct 20, 2025 BUY Strong Buy
+5.5% avg upside
36 analysts
$175.00
16.21% Upside
 +1.2%
COTY
Coty
 Oct 17, 2025 HOLD Hold
+129.6% avg upside
22 analysts
 — -52.5%
OLPX
Olaplex Holdings
 Aug 26, 2025 HOLD Hold
-2.9% avg upside
12 analysts
 — +40.4%
WALD
Waldencast
 Aug 19, 2025 HOLD Buy
+38.5% avg upside
6 analysts
 — -18.3%
CLX
Clorox
 May 06, 2025 HOLD Hold
+6.9% avg upside
24 analysts
 — -30.3%
CL
Colgate-Palmolive
 Jan 31, 2025 BUY Strong Buy
+3.1% avg upside
32 analysts
$110.00
21.51% Upside
 +6.7%
HELE
Helen Of Troy
 Jan 09, 2025 HOLD Buy
+274.6% avg upside
8 analysts
 — -68.7%
NWL
Newell Brands
 Feb 11, 2024 HOLD Buy
+61.6% avg upside
14 analysts
 — +4.2%
SKIN
Beauty Health
 Nov 14, 2023 SELL Hold
+408.7% avg upside
11 analysts
 — -28.8%
SPB
Spectrum Brands Holdings
 Jul 12, 2022 HOLD Strong Buy
-8.8% avg upside
17 analysts
 — +1.9%
EPC
Edgewell Personal Care
 Jul 13, 2021 HOLD Buy
+55.8% avg upside
12 analysts
 — -13.3%
YSG
Yatsen Holding
 Jul 13, 2021 HOLD Hold
-78.0% avg upside
2 analysts
 — -83.7%
KMB
Kimberly Clark
 Jan 22, 2021 BUY Buy
+22.2% avg upside
30 analysts
$155.00
52.79% Upside
 +12.2%
ENR
Energizer Holdings
 Jan 22, 2021 BUY Buy
+47.8% avg upside
12 analysts
$51.00
155.46% Upside
 -16.6%
VVV
Valvoline
 Jan 08, 2021 SELL Strong Buy
+5.9% avg upside
26 analysts
$23.00
38.62% Downside
 -49.8%
NUS
Nu Skin
 Oct 02, 2020 HOLD Buy
+1091.9% avg upside
6 analysts
$58.00
1064.69% Upside
 -23.9%
🔒 17 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Olivia Tong — Frequently Asked Questions
How accurate are Olivia Tong's stock ratings?
Based on the calls 13Foresight could measure, about 33% of Olivia's ratings were profitable over a one-year hold, with an average return of -18.8% per rating, or -33.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Olivia ranked on 13Foresight?
Olivia Tong is currently ranked #2469 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Olivia cover?
Olivia most recently has ratings on ELF, EL, ULTA, SBH, CHD, BBWI, PG, COTY, OLPX, WALD, CLX, CL and 10 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.